Predictors of survival in metastatic melanoma patients with leptomeningeal disease (LMD).

Sherise D FergusonShivani BindalRoland L BassettLauren E HayduIan E McCutcheonAmy B HeimbergerJing LiBarbara J O'BrienNandita Guha-ThakurtaMichael T TetzlaffHussein TawbiMichael A DaviesIsabella C Glitza

Published in: Journal of neuro-oncology (2019)

Despite their overall poor prognosis a subset of melanoma patients with LMD achieve longer survival. The factors associated with outcomes may be used to guide patient management and to inform the design of future clinical trials for this population.

Keyphrases

poor prognosis
long non coding rna
clinical trial
free survival
case report
cerebrospinal fluid
type diabetes
small cell lung cancer
metabolic syndrome
insulin resistance
skin cancer
study protocol
phase iii